Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Frontiers in Bioscience (Scholar Edition)
|
December 29, 2011
Gene-based continuous expression of FVIIa for the treatment of hemophilia
Paris Margaritis
Thrombosis Research
|
February 13, 2010
Long-term expression of canine FVIIa in hemophilic dogs
Paris Margaritis
Thrombosis Research
|
August 12, 2008
Over-expression of factor VIIa in vivo
Paris Margaritis
Thrombosis Research
|
May 22, 2016
8(th) Symposium on Hemostasis: Translational and Basic Science Discoveries
Paris Margaritis, Nigel S Key
Seminars in Hematology
|
January 24, 2006
Advances in gene therapy using factor VIIa in hemophilia
Paris Margaritis, Katherine A High
Blood
|
June 25, 2014
The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo
Giulia Pavani, Lacramioara Ivanciu, Armida Faella, et al.
The Journal of Clinical Investigation
|
April 2, 2004
Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII
Paris Margaritis, Valder R Arruda, Majed Aljamali, et al.
The Journal of Biological Chemistry
|
July 23, 2013
Cellular localization and characterization of cytosolic binding partners for Gla domain-containing proteins PRRG4 and PRRG2
Mustafa N Yazicioglu, Luca Monaldini, Kirk Chu, et al.
The Journal of Clinical Investigation
|
April 10, 2008
Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality
Majed N Aljamali, Paris Margaritis, Alexander Schlachterman, et al.
Blood
|
February 18, 2011
Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivo
Paris Margaritis, Elise Roy, Armida Faella, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Frontiers in Bioscience (Scholar Edition)
|
December 29, 2011
Gene-based continuous expression of FVIIa for the treatment of hemophilia
Paris Margaritis
Thrombosis Research
|
February 13, 2010
Long-term expression of canine FVIIa in hemophilic dogs
Paris Margaritis
Thrombosis Research
|
August 12, 2008
Over-expression of factor VIIa in vivo
Paris Margaritis
Thrombosis Research
|
May 22, 2016
8(th) Symposium on Hemostasis: Translational and Basic Science Discoveries
Paris Margaritis, Nigel S Key
Seminars in Hematology
|
January 24, 2006
Advances in gene therapy using factor VIIa in hemophilia
Paris Margaritis, Katherine A High
Blood
|
June 25, 2014
The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo
Giulia Pavani, Lacramioara Ivanciu, Armida Faella, et al.
The Journal of Clinical Investigation
|
April 2, 2004
Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII
Paris Margaritis, Valder R Arruda, Majed Aljamali, et al.
The Journal of Biological Chemistry
|
July 23, 2013
Cellular localization and characterization of cytosolic binding partners for Gla domain-containing proteins PRRG4 and PRRG2
Mustafa N Yazicioglu, Luca Monaldini, Kirk Chu, et al.
The Journal of Clinical Investigation
|
April 10, 2008
Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality
Majed N Aljamali, Paris Margaritis, Alexander Schlachterman, et al.
Blood
|
February 18, 2011
Catalytic domain modification and viral gene delivery of activated factor VII confers hemostasis at reduced expression levels and vector doses in vivo
Paris Margaritis, Elise Roy, Armida Faella, et al.
Page
of 3